
Duncan Pharma Private Limited
About Duncan Pharma Private Limited
Data last updated:
Duncan Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 May 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN2005PTC056343.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Varadarajan Dhivyalakshmi and Ida Ebenezar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Old No.9 New No.1218th Avenue Ashok Nagar, Chennai, Tamil Nadu, India – 600083.
As per the financials filed for FY 2020, the company reported a revenue of ₹22.95 Lakh, a decline of 1% compared to the previous year. For the same year it recorded a net loss of ₹6.91 Lakh (net margin -30.1%) and EBITDA of -₹6.45 Lakh (EBITDA margin -28.1%). Revenue has declined at a compounded annual rate (CAGR) of 45% over three years and 53% over five years.
As per MCA filings, the company has open charges of ₹1.22 Cr on record. Court records list 3 cases involving the company, including 3 filed against it.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Duncan Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressOld No.9 New No.1218th Avenue Ashok Nagar, Chennai, Tamil Nadu, India – 600083
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Duncan Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Duncan Pharma Private Limited
FY 2025 filings availableDuncan Pharma Private Limited reported revenue of ₹22.95 Lakh (down 1% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 53% over five years, including a 1% fall in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹22.95 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6.45 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.91 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -28.1% | ||||
| Net Profit Margin | -30.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Duncan Pharma Private Limited, buy the company report.
Board of directors of Duncan Pharma Private Limited
Duncan Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Varadarajan Dhivyalakshmi Also directs: Kniss Laboratories Private Limited | Director | 20 Apr 2020 | 6 Years 6 Months | Current |
| Ida Ebenezar | Director | 20 Apr 2020 | 6 Years 6 Months | Current |
Peer comparison
Duncan Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sun Medilab Private Limited | ₹23.05 Lakh (FY 2025) | -3.0% | New Delhi, Delhi, India | |||
| S.D.R.Pharmaceuticals Private Limited | ₹23.05 Lakh (FY 2022) | 14.0% | Lucknow, Uttar Pradesh, India | |||
| Bionexy Lifesciences Private Limited | ₹23.04 Lakh (FY 2023) | -73.0% | Secunderabad, Telangana, India | |||
| Usm Enterprises Private Limited | ₹23.03 Lakh (FY 2023) | 16.0% | Karnal, Haryana, India | |||
| Nucidem Lifesciences Private Limited | ₹23.02 Lakh (FY 2024) | -52.0% | New Delhi, Delhi, India | |||
| Duncan Pharma Private Limitedthis company | ₹22.95 Lakh (FY 2020) | -₹6.91 Lakh | -30.1% | -1.0% | Chennai, Tamil Nadu, India | |
| Kenko Skein Private Limited | ₹22.94 Lakh (FY 2025) | Kalwad, Rajasthan, India | ||||
| TLL Herbal Limited | ₹22.88 Lakh (FY 2025) | 105.0% | Surat, Gujarat, India | |||
| Eco Med Remedies Private Limited | ₹22.84 Lakh (FY 2024) | -2.0% | Kalyan, Maharashtra, India | |||
| Yash Healthcare Private Limited | ₹22.81 Lakh (FY 2025) | 128.0% | Raisen, Madhya Pradesh, India | |||
| Muse Healthcare Private Limited | ₹22.76 Lakh (FY 2025) | -19.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Duncan Pharma Private Limited, buy the company report.
Auditor
Duncan Pharma Private Limited is audited by YASHWANTH PESALA & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| YASHWANTH PESALA & ASSOCIATES | FY 2020 | 018009S |
Shareholding
The shareholding of Duncan Pharma Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Duncan Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Nov 2010 | 10251783 | Through Dy. Director of Industries Single Window Clearance Agency | ₹6.6 Lakh | Open | |
| 23 Jun 2006 | 80025310 | Karur Vysya Bank Limited | ₹40 Lakh | Open | |
| 23 Jun 2006 | 90324850 | Karur Vysya Bank Ltd. | ₹75 Lakh | Open |
To see the full charge records of Duncan Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Duncan Pharma Private Limited has 3 court cases on record: 3 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
| District courts | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Criminal miscellaneous application | Filed against the company by an individual | Disposed |
| High Court, TAMIL NADU | Civil suit | Filed against the company by Cadila Healthcare Ltd | Disposed |
| High Court, TAMIL NADU | Original application | Filed against the company by Cadila Healthcare Ltd | Disposed |
To see the full case history of Duncan Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Duncan Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Duncan Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Duncan Pharma Private Limited has 5 board changes on record since 2009: 2 appointments and 3 cessations. The latest: Hemalatha Varadarajan ceased to be Director on 08 Jul 2020.
Frequently asked questions
Duncan Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 May 2005 (21+ years old) and is registered under CIN U24231TN2005PTC056343.
Duncan Pharma has 2 current directors:
- Varadarajan Dhivyalakshmi - Director
- Ida Ebenezar - Director
The latest financial statements of Duncan Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Duncan Pharma is U24231TN2005PTC056343. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Duncan Pharma has 3 court cases on record: 3 filed against it. Most are in the high courts.
Duncan Pharma was incorporated on 18 May 2005, making it 21+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Duncan Pharma by revenue are Sun Medilab Private Limited, S.D.R.Pharmaceuticals Private Limited, Bionexy Lifesciences Private Limited, Usm Enterprises Private Limited, Nucidem Lifesciences Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Hemalatha Varadarajan ceased to be Director on 08 Jul 2020. Muthiah Varadarajan Dhanalakshmi ceased to be Director on 08 Jul 2020. Ida Ebenezar was appointed as Director on 20 Apr 2020. Duncan Pharma has 5 board changes on record in total.
The registered office of Duncan Pharma is at Old No.9 New No.1218th Avenue Ashok Nagar, Chennai, Tamil Nadu, India – 600083.
Duncan Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Duncan Pharma has open charges of ₹1.22 Cr and no satisfied charges on record as per latest MCA filings.

